"Olfaction Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.
Descriptor ID |
D000857
|
MeSH Number(s) |
C10.597.751.600 C23.888.592.763.550
|
Concept/Terms |
Cacosmia- Cacosmia
- Cacosmias
- Dysosmia
- Dysosmias
|
Below are MeSH descriptors whose meaning is more general than "Olfaction Disorders".
Below are MeSH descriptors whose meaning is more specific than "Olfaction Disorders".
This graph shows the total number of publications written about "Olfaction Disorders" by people in this website by year, and whether "Olfaction Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Olfaction Disorders" by people in Profiles.
-
Spadera L, Viola P, Pisani D, Scarpa A, Malanga D, Sorrentino G, Madini E, Laria C, Aragona T, Leopardi G, Maggiore G, Ciriolo M, Boccuto L, Pizzolato R, Abenavoli L, Cassandro C, Ralli M, Cassandro E, Chiarella G. Sudden olfactory loss as an early marker of COVID-19: a nationwide Italian survey. Eur Arch Otorhinolaryngol. 2021 Jan; 278(1):247-255.
-
Chiarella G, Pizzolato R, Malanga D, Pisani D, Abenavoli L, Viola P. Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia? Rev Recent Clin Trials. 2020; 15(3):244-245.
-
McEwen DP, Koenekoop RK, Khanna H, Jenkins PM, Lopez I, Swaroop A, Martens JR. Hypomorphic CEP290/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons. Proc Natl Acad Sci U S A. 2007 Oct 02; 104(40):15917-22.
-
Seibel MM, Claman P, Oskowitz SP, McArdle C, Weinstein FG. Events surrounding the initiation of puberty with long term subcutaneous pulsatile gonadotropin-releasing hormone in a female patient with Kallman's syndrome. J Clin Endocrinol Metab. 1985 Sep; 61(3):575-9.